News search

    E.g., 01/06/2024
    E.g., 01/06/2024
    Carla Rothlin
    About the CNIC
    19 Dec 2023
    Carla Rothlin: “Research is an intellectual challenge that you can take up throughout your life”

    Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School
    Foto de grupo Jacardi
    About the CNIC
    29 Nov 2023
    CNIC and the i+12 Institute participate in the most ambitious EU project to reduce the burden of cardiovascular diseases and diabetes

    CNIC and the i+12 Institute co-lead one of the working groups of this initiative.
    Representative results from participants showing atherosclerosis progression (left) and regression (disappearance of plaques, right) in arteries of the neck (carotids) and groin (femorals). Each image pair shows the results of the initial study at baseline and the follow-up study of the same artery 6 years later. The images show representative vascular ultrasound images on the right and 3-dimensional reconstructions on the left.
    Research
    20 Nov 2023
    JACC: Younger people are more vulnerable to the effects of cardiovascular risk associated with high blood cholesterol and hypertension

    Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough
    About the CNIC
    17 Nov 2023
    Dr. Francisco Sánchez-Madrid awarded the 2023 Robert Koch Prize

    This work is of fundamental importance for understanding the immune system and its reactions
    David Sancho
    About the CNIC
    31 Oct 2023
    David Sancho wins the 28th Carmen and Severo Ochoa Award for Research in Molecular Biology

    Dr Sancho heads the CNIC Immunobiology Laboratory, whose work focuses on research into the function of dendritic cells and macrophages, as key immune cells that modulate immunity and inflammation, and the use of these cells in immunotherapy in a wide range of diseases
    About the CNIC
    30 Oct 2023
    Dr Valentín Fuster receives the AstraZeneca Foundation Honorific Award for Excellence in Scientific Research

    The Honorific Award for Excellence in Scientific Research is awarded in recognition of the career of scientists who have contributed to the generation of knowledge and advances in their field of specialization
    Generación de células dendríticas post-sinápticas. La imagen muestra los contactos intercelulares entre las células dendríticas y los linfocitos T. Células Dendríticas (verde) y los linfocitos T (azul y rosa)
    Research
    26 Oct 2023
    Nature Communications: Spanish scientists identify changes in dendritic cells during the immune response with promising implications for vaccine design

    Scientists at the CNIC and Hospital de la Princesa-UAM have identified profound changes taking place in dendritic cells during antigen presentation to a lymphocyte via intimate contact called an immune synapse
    De izquierda a derecha: Cristina Sanchez-Ramos, Nieves Garcia-Quintans, David Morera, Mariya Lytvyn, Juan A Bernal, Mª Ángeles Sanguino, Daniel Martín Perez, Fernando de Benito, David Sanz y Emilio Camafeita
    Research
    23 Oct 2023
    Nature Communications: Spanish scientists discover a possible treatment for a heart condition that causes an estimated 20% of sudden deaths among athletes

    This disease, which can trigger sudden death in elite athletes, is caused by genetic mutations that affect proteins responsible for connecting and coordinating the muscle cells (myocytes) in the myocardium the heart’s muscular wall
    Research
    2 Oct 2023
    Diabetes Care: Obesity, high blood pressure, and lipid imbalance trigger a progressive loss of energy generation capacity in the heart

    Scientists at the CNIC have discovered that metabolic cardiovascular risk factors diminish the capacity of the heart to use glucose as an energy source
    Participantes del congreso junto al Dr. Valentín Fuster
    About the CNIC
    27 Sep 2023
    CNIC hosts symposium of the world’s major cardio-oncology summit

    The International Cardio-Oncology Society (ICOS), the Spanish Society of Cardiology (SEC), the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Haematology and Hemotherapy (SEHH) organised the Global Cardio Oncology Summit 2023 between 27-30 September in Madrid.